Concepedia

Poulabi Banerjee

PB

Statistics

Publications

26

Citations

3.8K

H-Index

20

Active since

1997

Affiliations

Regeneron (United States)(Current)

Sanofi (France)

Icahn School of Medicine at Mount Sinai

University of Pennsylvania

Université du Québec à Chicoutimi

Poulabi Banerjee is an author at Regeneron (United States) specializing in medicine, lipid-lowering therapy, and pharmacotherapy.

Publications per year

1997–2024

26

Publications

26

Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease

Frederick E. Dewey, Viktoria Gusarova, Richard L. Dunbar et al. · New England Journal of Medicine · 2017 · 875 citations · Full text

Medicine, Genetics, Molecular Genetics +15

Evinacumab for Homozygous Familial Hypercholesterolemia

Frederick J. Raal, Robert S. Rosenson, Laurens F. Reeskamp et al. · New England Journal of Medicine · 2020 · 764 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial

Amy Damask, Philippe Gabríel Steg, Gregory G. Schwartz et al. · Circulation · 2019 · 246 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia

Zahid Ahmad, Poulabi Banerjee, Sara Hamon et al. · Circulation · 2019 · 245 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

An association study of 43 SNPs in 16 candidate genes with atorvastatin response

John F. Thompson, M. Man, Keith Johnson et al. · The Pharmacogenomics Journal · 2005 · 214 citations

Medicine, Genetics, Molecular Genetics +15

1–5 of 26